Phyto Extractions Inc (CSE:XTRX) (FRA:D2EP), formerly named Adastra Labs Holdings Ltd, has announced that interim CEO and director J. Scott Munro is moving on.
The company said it has identified a new permanent candidate for the CEO post and an additional director to fill the vacancy created by Munro's transition.
It added that it expects to announce the appointments in the immediate future and that such appointments will continue the great work completed to date that has positioned the brand as a provider of quality cannabis products.
READ: Phyto Extractions says now producing cannabis shatter products after commissioning of new hydrocarbon extraction equipment
Phyto Extractions said Munro served as a seasoned driver, whose role as Interim CEO and director steadily steered the company on its continued growth trajectory, overseeing a new project category launch and several corporate operational improvements.
"Scott Munro has made his own patch on the tapestry of Phyto Extractions' history,” said Donald Dinsmore, chief operating officer, in a statement.
“Phyto Extractions has seen vast improvements across operations and the financial health of the company during his tenure, which isn't an easy task for any senior manager. We are grateful for Munro's support and the improvements he has made for the company during his period as interim CEO and we wish him all the best in his new endeavors."
The company said it intends to secure an ever-increasing market share and position itself as one of the leading cannabis brand name products with the help of its wholly-owned subsidiaries Adastra Labs Inc and testing lab Chemia Analytics Inc.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham